Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 16 of 16

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Subconjuctival Topotecan In Fibrin Sealant In The Treatment Of Transgenic Murine Retinoblastoma

J. Tsui; K.R. Van Quill; C.L. Dalgard; L. Lee; H.E. Grossniklaus; H.F. Edelhauser; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2289.

ARVO Annual Meeting Abstract May 2006

Selective Inhibiton of Calcineurin / Nuclear Factor of Activated T–Cells Signaling by the Cell Permeable Peptide 11R–VIVIT is Insufficient for Induction of Apoptosis in Retinoblastoma Cells

C.L. Dalgard; J. Tsui; K.R. Van Quill; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2808.

ARVO Annual Meeting Abstract May 2006

Expression of Truncated Mutant pRB in Retinoblastoma

J.L. Perez; K.R. Van Quill; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2809.

ARVO Annual Meeting Abstract May 2005

Subconjunctival Carboplatin in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma

K.R. Van Quill; P.K. Dioguardi; C.T. Tong; J.A. Gilbert; T.M. Aaberg, Jr; H.E. Grossniklaus; H.F. Edelhauser; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1108.

ARVO Annual Meeting Abstract May 2005

Can RB1 Mutation Analysis be Used to Predict Disease Expression in Patients With Heritable Retinoblastoma?

J. Qi; R.M. Conway; K.B. Desai; K.R. Van Quill; S.A. Howard; T. Tsai; E.D. Eliseeva; V. Weinberg; B. Gallie; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3387.

ARVO Annual Meeting Abstract May 2005

Antiproliferative Effects of Iron Chelators in Human Retinoblastoma Cells

E. Aghaian; J. Qi; K.R. Van Quill; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3389.

ARVO Annual Meeting Abstract May 2005

Socioeconomic Predictors of Outcome in Hereditary Retinoblastoma

Y. Pan; R.M. Conway; L. Fine; J. Hwang; K.R. Van Quill; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3396.

ARVO Annual Meeting Abstract May 2005

Treatment of Transgenic Murine Retinoblastoma With 4–Iodo–3–Nitrobenzamide (INO2BA), a Novel Chemotherapeutic Agent

K. Ramonas; J. Qi; C.T. Tong; S.A. Howard; K.R. Van Quill; N. Green; H.E. Grossniklaus; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3422.

ARVO Annual Meeting Abstract May 2005

Effects of Celecoxib in Human Retinoblastoma Cell Lines and in a Transgenic Murine Model of Retinoblastoma

C.T. Tong; S.A. Howard; H.R. Shah; K.R. Van Quill; E.T. Lin; H.E. Grossniklaus; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4246.

ARVO Annual Meeting Abstract May 2004

The Chemotherapeutic Potential of Beta–lapachone in Retinoblastoma

H. Shah; R.M. Conway; S. Howard; K.R. Van Quill; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3554.

ARVO Annual Meeting Abstract May 2004

Antiproliferative effects of the synthetic retinoid, Targretin, in human retinoblastoma cells

A. Gupta; K.R. Van Quill; J. Mendeleyev; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3556.

ARVO Annual Meeting Abstract May 2004

Heritable Retinoblastoma: Genotype–Phenotype Correlations

R.M. Conway; K.B. Desai; K.R. Van Quill; S. Howard; B. Gallie; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3557.

ARVO Annual Meeting Abstract May 2003

Genotype-phenotype Correlations in Heritable Retinoblastoma

K.B. Desai; K.R. Van Quill; T. Tsai; B. Gallie; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1574.

ARVO Annual Meeting Abstract May 2003

Effects of 13-cis Retinoic Acid in Human Retinoblastoma Cell Lines

C.T. Tong; K.R. Van Quill; N.A. Sharara; A. Gupta; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1579.

ARVO Annual Meeting Abstract May 2003

Effects of All-trans Retinoic Acid and 9-cis Retinoic Acid in Human Retinoblastoma Cell Lines

A. Gupta; K.R. Van Quill; N.A. Sharara; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1580.

ARVO Annual Meeting Abstract May 2003

The Potential Clinical Utility of Fenretinide in the Treatment of Retinoblastoma: In Vitro Study

N.A. Sharara; K.R. Van Quill; J.M. O'Brien

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):1581.

Advertisement